Skip to main content
  • Research Identifies Causes and Possible Treatments for Deadly Diseases Affecting Children in Developing Countries

    University of Maryland School of Medicine Researchers Explore How to Prevent Diarrheal Diseases, a Leading Cause of Death in Young Children in Sub-Saharan Africa and South Asia

    Learn More
  • UM SOM Received $2.47 Million Grant To Develop Traveler's Diarrhea Vaccine

    CVD Researchers to Develop a Vaccine to Protect against Shigella and Certain E. Coli

  • CVD Director Takes Key Role to Promote Disease Prevention

    Dr. Kathleen Neuzil Elected to National Foundation for Infectious Diseases Board of Directors

    Learn More

Center for Vaccine Development (CVD)

Preventing disease and saving lives through development and delivery of vaccines

For over 40 years, the CVD at the University of Maryland School of Medicine (UM SOM) in Baltimore, MD has worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations. The CVD is an academic enterprise engaged in the full range of vaccinology from basic laboratory research through vaccine development, pre-clinical and clinical evaluation, large-scale pre-licensure field studies, and post-licensure assessments.


Click on the "News" link above to read more about CVD in the news.

Hot off the Press

Fabien Fuche, PhD, Ousmane Sow, Raphael Simon, PhD, and Sharon Tennant, PhD co-authored Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed, September 2017.

RosaÃngela Salerno-Goncalves, PhD, David Lou, Tasmia Rezwanul, and Marcelo B. Sztein, MD were among the co-authors on Use of a Novel Antigen Expressing System to Study the Salmonella enterica Serovar Typhi Protein Recognition by T cells, 5 September 2017.

‌‌‌Learn More

Follow Us

Give to the CVD

Volunteer Opportunities